NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -16.16% | -5.74% | 5.79% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.16% | -5.74% | 5.79% | -- | -- |
| Cost of Revenue | -24.02% | -11.35% | 4.40% | -- | -- |
| Gross Profit | 8.18% | 8.43% | 8.63% | -- | -- |
| SG&A Expenses | 319.03% | 188.71% | 82.20% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.53% | 44.20% | 29.44% | -- | -- |
| Operating Income | -8,633.61% | -5,920.75% | -2,836.79% | -- | -- |
| Income Before Tax | 696.18% | -772.95% | -985.53% | -- | -- |
| Income Tax Expenses | -481.48% | -1,064.35% | -486,800.00% | -- | -- |
| Earnings from Continuing Operations | 515.39% | -33.78% | -537.36% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 74.44% | -80.66% | -333.18% | -- | -- |
| Net Income | 1,338.31% | -57.97% | -502.69% | -- | -- |
| EBIT | -8,633.61% | -5,920.75% | -2,836.79% | -- | -- |
| EBITDA | -4,755.11% | -3,058.98% | -1,381.91% | -- | -- |
| EPS Basic | 87.44% | -396.62% | -404.03% | -- | -- |
| Normalized Basic EPS | -304.43% | -317.99% | -331.56% | -- | -- |
| EPS Diluted | 79.66% | -412.83% | -404.72% | -- | -- |
| Normalized Diluted EPS | -324.05% | -327.81% | -331.56% | -- | -- |
| Average Basic Shares Outstanding | 2,491.67% | 1,281.58% | 71.49% | -- | -- |
| Average Diluted Shares Outstanding | 4,626.28% | 3,078.72% | 160.09% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |